Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type

doi:10.1038/ng.2931

. 2014 May;46(5):438-43.

doi: 10.1038/ng.2931. Epub 2014 Mar 23.

Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type

Leora Witkowski¹, Jian Carrot-Zhang², Steffen Albrecht³, Somayyeh Fahiminiya⁴, Nancy Hamel⁵, Eva Tomiak⁶, David Grynspan⁷, Emmanouil Saloustros⁸, Javad Nadaf⁴, Barbara Rivera⁹, Catherine Gilpin⁶, Ester Castellsagué⁹, Rachel Silva-Smith¹⁰, François Plourde¹⁰, Mona Wu⁹, Avi Saskin¹¹, Madeleine Arseneault⁴, Rouzan G Karabakhtsian¹², Elizabeth A Reilly¹³, Frederick R Ueland¹³, Anna Margiolaki⁸, Kitty Pavlakis¹⁴, Sharon M Castellino¹⁵, Janez Lamovec¹⁶, Helen J Mackay¹⁷, Lawrence M Roth¹⁸, Thomas M Ulbright¹⁸, Tracey A Bender¹⁸, Vassilis Georgoulias⁸, Michel Longy¹⁹, Andrew Berchuck²⁰, Marc Tischkowitz²¹, Inga Nagel²², Reiner Siebert²², Colin J R Stewart²³, Jocelyne Arseneau²⁴, W Glenn McCluggage²⁵, Blaise A Clarke²⁶, Yasser Riazalhosseini⁴, Martin Hasselblatt²⁷, Jacek Majewski⁴, William D Foulkes²⁸

Affiliations

¹ 1] Program in Cancer Genetics, Department of Oncology and Human Genetics, McGill University, Montreal, Quebec, Canada. [2] Department of Human Genetics, McGill University, Montreal, Quebec, Canada. [3].
² 1] Department of Human Genetics, McGill University, Montreal, Quebec, Canada. [2] McGill University and Génome Québec Innovation Centre, Montreal, Quebec, Canada. [3].
³ Department of Pathology, Montreal Children's Hospital, McGill University Health Centre, McGill University, Montreal, Quebec, Canada.
⁴ 1] Department of Human Genetics, McGill University, Montreal, Quebec, Canada. [2] McGill University and Génome Québec Innovation Centre, Montreal, Quebec, Canada.
⁵ 1] Program in Cancer Genetics, Department of Oncology and Human Genetics, McGill University, Montreal, Quebec, Canada. [2] Department of Medical Genetics, Research Institute, McGill University Health Centre, Montreal, Quebec, Canada.
⁶ Department of Genetics, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, Ontario, Canada.
⁷ Department of Pathology and Laboratory Medicine, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, Ontario, Canada.
⁸ Hereditary Cancer Clinic, Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Greece.
⁹ 1] Program in Cancer Genetics, Department of Oncology and Human Genetics, McGill University, Montreal, Quebec, Canada. [2] Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
¹⁰ 1] Program in Cancer Genetics, Department of Oncology and Human Genetics, McGill University, Montreal, Quebec, Canada. [2] Department of Medical Genetics, Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.
¹¹ Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
¹² 1] Department of Pathology and Laboratory Medicine, Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA. [2].
¹³ Department of Pathology and Laboratory Medicine, Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA.
¹⁴ Pathology Department, National and Kapodistrian University of Athens, Athens, Greece.
¹⁵ Department of Pediatrics, Hematology/Oncology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
¹⁶ Department of Pathology, Institute of Oncology, Ljubljana, Slovenia.
¹⁷ Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
¹⁸ Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
¹⁹ Institut Bergonié, Unité d'Oncogénétique, Bordeaux, France.
²⁰ Division of Gynecologic Oncology, Duke University Medical Center, Durham, North Carolina, USA.
²¹ Department of Medical Genetics, University of Cambridge, Cambridge, UK.
²² Institute of Human Genetics, Christian Albrechts University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
²³ School for Women's and Infants' Health, University of Western Australia, Perth, Western Australia, Australia.
²⁴ Department of Pathology, Royal Victoria Hospital, McGill University Health Centre, McGill University, Montreal, Quebec, Canada.
²⁵ Department of Pathology, Royal Group of Hospitals Trust, Belfast, UK.
²⁶ Department of Pathology Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada.
²⁷ Institute of Neuropathology, University Hospital-Münster, Münster, Germany.
²⁸ 1] Program in Cancer Genetics, Department of Oncology and Human Genetics, McGill University, Montreal, Quebec, Canada. [2] Department of Medical Genetics, Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada. [3] Department of Human Genetics, McGill University, Montreal, Quebec, Canada. [4] Department of Medical Genetics, Research Institute, McGill University Health Centre, Montreal, Quebec, Canada.

PMID: 24658002
DOI: 10.1038/ng.2931

Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type

Leora Witkowski et al. Nat Genet. 2014 May.

. 2014 May;46(5):438-43.

doi: 10.1038/ng.2931. Epub 2014 Mar 23.

Authors

Affiliations

¹ 1] Program in Cancer Genetics, Department of Oncology and Human Genetics, McGill University, Montreal, Quebec, Canada. [2] Department of Human Genetics, McGill University, Montreal, Quebec, Canada. [3].
² 1] Department of Human Genetics, McGill University, Montreal, Quebec, Canada. [2] McGill University and Génome Québec Innovation Centre, Montreal, Quebec, Canada. [3].
³ Department of Pathology, Montreal Children's Hospital, McGill University Health Centre, McGill University, Montreal, Quebec, Canada.
⁴ 1] Department of Human Genetics, McGill University, Montreal, Quebec, Canada. [2] McGill University and Génome Québec Innovation Centre, Montreal, Quebec, Canada.
⁵ 1] Program in Cancer Genetics, Department of Oncology and Human Genetics, McGill University, Montreal, Quebec, Canada. [2] Department of Medical Genetics, Research Institute, McGill University Health Centre, Montreal, Quebec, Canada.
⁶ Department of Genetics, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, Ontario, Canada.
⁷ Department of Pathology and Laboratory Medicine, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, Ontario, Canada.
⁸ Hereditary Cancer Clinic, Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Greece.
⁹ 1] Program in Cancer Genetics, Department of Oncology and Human Genetics, McGill University, Montreal, Quebec, Canada. [2] Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
¹⁰ 1] Program in Cancer Genetics, Department of Oncology and Human Genetics, McGill University, Montreal, Quebec, Canada. [2] Department of Medical Genetics, Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.
¹¹ Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
¹² 1] Department of Pathology and Laboratory Medicine, Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA. [2].
¹³ Department of Pathology and Laboratory Medicine, Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA.
¹⁴ Pathology Department, National and Kapodistrian University of Athens, Athens, Greece.
¹⁵ Department of Pediatrics, Hematology/Oncology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
¹⁶ Department of Pathology, Institute of Oncology, Ljubljana, Slovenia.
¹⁷ Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
¹⁸ Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
¹⁹ Institut Bergonié, Unité d'Oncogénétique, Bordeaux, France.
²⁰ Division of Gynecologic Oncology, Duke University Medical Center, Durham, North Carolina, USA.
²¹ Department of Medical Genetics, University of Cambridge, Cambridge, UK.
²² Institute of Human Genetics, Christian Albrechts University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
²³ School for Women's and Infants' Health, University of Western Australia, Perth, Western Australia, Australia.
²⁴ Department of Pathology, Royal Victoria Hospital, McGill University Health Centre, McGill University, Montreal, Quebec, Canada.
²⁵ Department of Pathology, Royal Group of Hospitals Trust, Belfast, UK.
²⁶ Department of Pathology Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada.
²⁷ Institute of Neuropathology, University Hospital-Münster, Münster, Germany.
²⁸ 1] Program in Cancer Genetics, Department of Oncology and Human Genetics, McGill University, Montreal, Quebec, Canada. [2] Department of Medical Genetics, Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada. [3] Department of Human Genetics, McGill University, Montreal, Quebec, Canada. [4] Department of Medical Genetics, Research Institute, McGill University Health Centre, Montreal, Quebec, Canada.

PMID: 24658002
DOI: 10.1038/ng.2931

Abstract

Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is the most common undifferentiated ovarian malignancy in women under 40 years of age. We sequenced the exomes of six individuals from three families with SCCOHT. After discovering segregating deleterious germline mutations in SMARCA4 in all three families, we tested DNA from a fourth affected family, which also carried a segregating SMARCA4 germline mutation. All the familial tumors sequenced harbored either a somatic mutation or loss of the wild-type allele. Immunohistochemical analysis of these cases and additional familial and non-familial cases showed loss of SMARCA4 (BRG1) protein in 38 of 40 tumors overall. Sequencing of cases with available DNA identified at least one germline or somatic deleterious SMARCA4 mutation in 30 of 32 cases. Additionally, the SCCOHT cell line BIN-67 had biallelic deleterious mutations in SMARCA4. Our findings identify alterations in SMARCA4 as the major cause of SCCOHT, which could lead to improvements in genetic counseling and new treatment approaches.

PubMed Disclaimer

Comment in

Genetics: SMARCA4 mutated in SCCOHT.
Errico A. Errico A. Nat Rev Clin Oncol. 2014 Jun;11(6):302. doi: 10.1038/nrclinonc.2014.63. Epub 2014 Apr 15. Nat Rev Clin Oncol. 2014. PMID: 24732945 No abstract available.

Cited by

Integrating phosphoproteome and transcriptome reveals new determinants of macrophage multinucleation.
Rotival M, Ko JH, Srivastava PK, Kerloc'h A, Montoya A, Mauro C, Faull P, Cutillas PR, Petretto E, Behmoaras J. Rotival M, et al. Mol Cell Proteomics. 2015 Mar;14(3):484-98. doi: 10.1074/mcp.M114.043836. Epub 2014 Dec 22. Mol Cell Proteomics. 2015. PMID: 25532521 Free PMC article.
Early-Onset Ovarian Cancer <30 Years: What Do We Know about Its Genetic Predisposition?
Horackova K, Janatova M, Kleiblova P, Kleibl Z, Soukupova J. Horackova K, et al. Int J Mol Sci. 2023 Nov 30;24(23):17020. doi: 10.3390/ijms242317020. Int J Mol Sci. 2023. PMID: 38069345 Free PMC article. Review.
Genomic alterations in neuroendocrine cancers of the ovary.
Yaghmour G, Prouet P, Wiedower E, Jamy OH, Feldman R, Chandler JC, Pandey M, Martin MG. Yaghmour G, et al. J Ovarian Res. 2016 Aug 26;9(1):52. doi: 10.1186/s13048-016-0259-2. J Ovarian Res. 2016. PMID: 27566252 Free PMC article.
SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T).
Papathomas TG, Oudijk L, Persu A, Gill AJ, van Nederveen F, Tischler AS, Tissier F, Volante M, Matias-Guiu X, Smid M, Favier J, Rapizzi E, Libe R, Currás-Freixes M, Aydin S, Huynh T, Lichtenauer U, van Berkel A, Canu L, Domingues R, Clifton-Bligh RJ, Bialas M, Vikkula M, Baretton G, Papotti M, Nesi G, Badoual C, Pacak K, Eisenhofer G, Timmers HJ, Beuschlein F, Bertherat J, Mannelli M, Robledo M, Gimenez-Roqueplo AP, Dinjens WN, Korpershoek E, de Krijger RR. Papathomas TG, et al. Mod Pathol. 2015 Jun;28(6):807-21. doi: 10.1038/modpathol.2015.41. Epub 2015 Feb 27. Mod Pathol. 2015. PMID: 25720320
Rare Hereditary Gynecological Cancer Syndromes.
Watanabe T, Soeda S, Endo Y, Okabe C, Sato T, Kamo N, Ueda M, Kojima M, Furukawa S, Nishigori H, Takahashi T, Fujimori K. Watanabe T, et al. Int J Mol Sci. 2022 Jan 29;23(3):1563. doi: 10.3390/ijms23031563. Int J Mol Sci. 2022. PMID: 35163487 Free PMC article. Review.

See all "Cited by" articles

References

1. J Pediatr Surg. 2012 Mar;47(3):588-92 - PubMed
1. Pol J Pathol. 2013 Dec;64(4):238-46 - PubMed
1. Int J Gynaecol Obstet. 2009 Apr;105(1):3-4 - PubMed
1. Am J Surg Pathol. 2011 Jun;35(6):933-5 - PubMed
1. J Mol Diagn. 2006 May;8(2):141-51 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- MedlinePlus Health Information
Molecular Biology Databases
- The Weizmann Institute of Science GeneCards and MalaCards databases
Research Materials
- Cellosaurus - a cell line knowledge resource
Miscellaneous
- NCI CPTAC Assay Portal

[1] J Pediatr Surg. 2012 Mar;47(3):588-92 - PubMed

[2] J Pediatr Surg. 2012 Mar;47(3):588-92 - PubMed

[3] Pol J Pathol. 2013 Dec;64(4):238-46 - PubMed

[4] Pol J Pathol. 2013 Dec;64(4):238-46 - PubMed

[5] Int J Gynaecol Obstet. 2009 Apr;105(1):3-4 - PubMed

[6] Int J Gynaecol Obstet. 2009 Apr;105(1):3-4 - PubMed

[7] Am J Surg Pathol. 2011 Jun;35(6):933-5 - PubMed

[8] Am J Surg Pathol. 2011 Jun;35(6):933-5 - PubMed

[9] J Mol Diagn. 2006 May;8(2):141-51 - PubMed

[10] J Mol Diagn. 2006 May;8(2):141-51 - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type

Affiliations

Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type

Authors

Affiliations

Abstract

Comment in

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

Research Materials

Miscellaneous

Abstract

Comment in

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

Research Materials

Miscellaneous